GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Tempo Scan Pacific Tbk (ISX:TSPC) » Definitions » Capex-to-Revenue

PT Tempo Scan Pacific Tbk (ISX:TSPC) Capex-to-Revenue : 0.03 (As of Jun. 2024)


View and export this data going back to 1994. Start your Free Trial

What is PT Tempo Scan Pacific Tbk Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

PT Tempo Scan Pacific Tbk's Capital Expenditure for the three months ended in Jun. 2024 was Rp-82,839.75 Mil. Its Revenue for the three months ended in Jun. 2024 was Rp3,335,251.37 Mil.

Hence, PT Tempo Scan Pacific Tbk's Capex-to-Revenue for the three months ended in Jun. 2024 was 0.03.


PT Tempo Scan Pacific Tbk Capex-to-Revenue Historical Data

The historical data trend for PT Tempo Scan Pacific Tbk's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Tempo Scan Pacific Tbk Capex-to-Revenue Chart

PT Tempo Scan Pacific Tbk Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.03 0.04 0.03 0.05 0.03

PT Tempo Scan Pacific Tbk Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.03 0.03 0.03 0.03

Competitive Comparison of PT Tempo Scan Pacific Tbk's Capex-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, PT Tempo Scan Pacific Tbk's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Tempo Scan Pacific Tbk's Capex-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PT Tempo Scan Pacific Tbk's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where PT Tempo Scan Pacific Tbk's Capex-to-Revenue falls into.



PT Tempo Scan Pacific Tbk Capex-to-Revenue Calculation

PT Tempo Scan Pacific Tbk's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-326650.562) / 13119784.556
=0.02

PT Tempo Scan Pacific Tbk's Capex-to-Revenue for the quarter that ended in Jun. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-82839.75) / 3335251.366
=0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PT Tempo Scan Pacific Tbk  (ISX:TSPC) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


PT Tempo Scan Pacific Tbk Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of PT Tempo Scan Pacific Tbk's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Tempo Scan Pacific Tbk Business Description

Traded in Other Exchanges
N/A
Address
Jalan H.R. Rasuna Said Kav. 3-4, Tempo Scan Tower, 16th Floor, Jakarta, IDN, 12950
PT Tempo Scan Pacific Tbk operates in the pharmaceutical business in Indonesia. It is engaged in the production of tablet/caplets, effervescent powders, liquid/syrup, cream and ointment, and capsule dosage forms and markets body care products. It operates through the following segments: The Pharmaceuticals segment, the Consumer Products and Cosmetics segment, and the Distribution Services segment. The company caters to both Indonesian and international markets.

PT Tempo Scan Pacific Tbk Headlines

No Headlines